Client Success
We leverage our unparalleled relationships across the life sciences ecosystem to connect the right leaders with the right companies.
Recent Client Success
Filter by placement
BOD|August 14, 2024
Board of Directors
Client Team Lead: Zach Charles
Client: Abeona Therapeutics
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Bernhardt G. Zeiher, MD, FCCP, FACP, and Eric Crombez, MD as new independent members to its Board of Directors. Dr. Zeiher brings more than 20 years of…
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Bernhardt G. Zeiher, MD, FCCP, FACP, and Eric Crombez, MD as new independent members to its Board of Directors. Dr. Zeiher brings more than 20 years of…
CEO|August 5, 2024
Chief Executive Officer
Client Team Lead: Molly Robb
Client: Fennec Pharmaceuticals
RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced the appointment of Mr. Jeff Hackman as its Chief Executive Officer (CEO) and a member of the Board…
RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced the appointment of Mr. Jeff Hackman as its Chief Executive Officer (CEO) and a member of the Board…
BOD|July 23, 2024
Board Director
Client Team Lead: John Spencer
Client: Cleveland Diagnostics, Inc.
Cleveland Diagnostics, Inc., a cancer biotechnology company, today announced the appointment of a new independent director, Dara Grantham Wright, to its Board of Directors. Wright’s extensive experience in life science research and clinical diagnostics will be an…
Cleveland Diagnostics, Inc., a cancer biotechnology company, today announced the appointment of a new independent director, Dara Grantham Wright, to its Board of Directors. Wright’s extensive experience in life science research and clinical diagnostics will be an…
CEO|July 15, 2024
Chief Executive Officer
Client Team Lead: Matt Toner
Client: AffyImmune
AffyImmune, a clinical-stage biotechnology company committed to developing novel, first-in-class CAR T cell therapies, today announced the appointment of Daniel Janse, Ph.D. as President and Chief Executive Officer. Dr. Janse brings twenty years of expertise and an extensive…
AffyImmune, a clinical-stage biotechnology company committed to developing novel, first-in-class CAR T cell therapies, today announced the appointment of Daniel Janse, Ph.D. as President and Chief Executive Officer. Dr. Janse brings twenty years of expertise and an extensive…
CEO|June 11, 2024
Chief Executive Officer
Client Team Lead: John Spencer
Client: AxoSim
AxoSim, a life science company building human brains in the lab at scale to heal memory, movement, and pain disorders, today announced the appointment of Alif Saleh as chief executive officer. With this appointment, co-founder and previous CEO…
AxoSim, a life science company building human brains in the lab at scale to heal memory, movement, and pain disorders, today announced the appointment of Alif Saleh as chief executive officer. With this appointment, co-founder and previous CEO…
VP|June 4, 2024
SVP, Operations
Client Team Lead: John Spencer
Client: G-CON
G-CON, the leader in sustainable cleanrooms, today announced Jim Hooper will be joining the organization as Sr. Vice President of Operations, effective immediately. He will lead global operations for PODs and US operations for G-CON Clean Solutions. Jim…
G-CON, the leader in sustainable cleanrooms, today announced Jim Hooper will be joining the organization as Sr. Vice President of Operations, effective immediately. He will lead global operations for PODs and US operations for G-CON Clean Solutions. Jim…
President|May 30, 2024
EVP and President, Clinical Diagnostics Group
Client Team Lead: John Spencer
Client: Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt will join the company as its new Executive Vice President and President of…
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt will join the company as its new Executive Vice President and President of…
BOD|May 23, 2024
Board Directors
Client Team Lead: Zach Charles
Client: atai Life Sciences
atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the appointment of Scott Braunstein, M.D., and Laurent Fischer, M.D., as independent directors…
atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the appointment of Scott Braunstein, M.D., and Laurent Fischer, M.D., as independent directors…
BOD|May 16, 2024
Board Director
Client Team Lead: Zach Charles
Client: ArriVent BioPharma, Inc.
ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of John Hohneker, M.D. to its Board of Directors. Dr. Hohneker brings over 30 years of…
ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of John Hohneker, M.D. to its Board of Directors. Dr. Hohneker brings over 30 years of…
Learn More About Our Search Opportunities
Need help finding the right opportunity? We'll be happy to help!